Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Jun;109(2):394–404. doi: 10.1111/j.1476-5381.1993.tb13582.x

Interactions between responses mediated by activation of adenosine A2 receptors and alpha 1-adrenoceptors in the rabbit isolated aorta.

H L Wiener 1, G P Thalody 1, S Maayani 1
PMCID: PMC2175693  PMID: 8395286

Abstract

1. This paper describes aspects of the functional antagonism between the responses mediated by activated alpha 1-adrenoceptors and adenosine A2 receptors in the adventitia- and endothelium-denuded aorta of the rabbit. 2. Adenosine A2 receptor agonists relaxed aortic rings pre-contracted with phenylephrine. The relaxation response was agonist concentration-dependent and saturable. The respective contractile and relaxation responses were stable, reproducible, and reversible. 3. Increasing the phenylephrine concentration caused a progressive attenuation of the action of adenosine A2 receptor agonists, consisting of a decreased maximal response and a dextral shift of the adenosine agonist concentration-response curve. This functional antagonism could be completely reversed upon removal of adenosine by either the addition of adenosine deaminase or by wash-out of the adenosine agonist from the tissue. The relaxation response to the adenosine A2 receptor partial agonists, N6-cyclohexyladenosine and R-(-)-N6-(2-phenylisopropyl)adenosine, was abolished at higher phenylephrine concentrations (e.g. 30 EC50). 4. A 1000 fold increase in the adenosine concentration was required to shift the value of the EC50 of phenylephrine six fold, while a similar increase in the value of the EC50 of adenosine could be elicited by only a 32 fold increase in the phenylephrine concentration. A 30 fold increase in the phenylephrine concentration shifted the value of the EC50 of 5'-N-ethylcarboxamidoadenosine four fold. 5. Analysis of the functional antagonism between the responses mediated by these receptors using the Black & Leff (1983) operational model of agonism allowed for the estimation of the agonist dissociation constant, KA, and the apparent efficacy, tau, for both phenylephrine and adenosine A2 receptor agonists. Increasing the concentration of phenylephrine reduced the value of tau for adenosine agonists in a concentration-dependent and saturable manner. Similarly, increasing the concentration of adenosine reduced the value of tau for phenylephrine in a concentration-dependent and saturable manner. The phenylephrine KA value obtained by the method of functional antagonism (1.9 microM) was similar to that obtained by the receptor inactivation method (2.1 microM). 6. Partial occlusion of the alpha 1-adrenoceptor by the alkylating agent, dibenamine, demonstrated that the magnitude of the adenosine A2 receptor-mediated relaxation was inversely proportional to the number of functional alpha 1-adrenoceptors. 7. It is concluded that the magnitude of functional antagonism is proportional to the stimulus elicited through either receptor. We propose that this tissue preparation and pair of receptors is a good model to study quantitative aspects of functional antagonism between activated receptors.

Full text

PDF
394

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balwierczak J. L., Sharif R., Krulan C. M., Field F. P., Weiss G. B., Miller M. J. Comparative effects of a selective adenosine A2 receptor agonist, CGS 21680, and nitroprusside in vascular smooth muscle. Eur J Pharmacol. 1991 Apr 17;196(2):117–123. doi: 10.1016/0014-2999(91)90416-n. [DOI] [PubMed] [Google Scholar]
  3. Belardinelli L., Linden J., Berne R. M. The cardiac effects of adenosine. Prog Cardiovasc Dis. 1989 Jul-Aug;32(1):73–97. doi: 10.1016/0033-0620(89)90015-7. [DOI] [PubMed] [Google Scholar]
  4. Black J. W., Leff P. Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci. 1983 Dec 22;220(1219):141–162. doi: 10.1098/rspb.1983.0093. [DOI] [PubMed] [Google Scholar]
  5. Buckner C. K., Saini R. K. On the use of functional antagonism to estimate dissociation constants for beta adrenergic receptor agonists in isolated guinea-pig trachea. J Pharmacol Exp Ther. 1975 Sep;194(3):565–574. [PubMed] [Google Scholar]
  6. Burnstock G. Dual control of local blood flow by purines. Ann N Y Acad Sci. 1990;603:31–45. doi: 10.1111/j.1749-6632.1990.tb37659.x. [DOI] [PubMed] [Google Scholar]
  7. Collis M. G., Brown C. M. Adenosine relaxes the aorta by interacting with an A2 receptor and an intracellular site. Eur J Pharmacol. 1983 Dec 9;96(1-2):61–69. doi: 10.1016/0014-2999(83)90529-0. [DOI] [PubMed] [Google Scholar]
  8. Cushing D. J., Brown G. L., Sabouni M. H., Mustafa S. J. Adenosine receptor-mediated coronary artery relaxation and cyclic nucleotide production. Am J Physiol. 1991 Aug;261(2 Pt 2):H343–H348. doi: 10.1152/ajpheart.1991.261.2.H343. [DOI] [PubMed] [Google Scholar]
  9. DeLean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978 Aug;235(2):E97–102. doi: 10.1152/ajpendo.1978.235.2.E97. [DOI] [PubMed] [Google Scholar]
  10. Eglen R. M., Montgomery W. W., Whiting R. L. Desensitization and functional antagonism by beta-adrenoceptor and muscarinic receptor agonists, respectively: a comparison with receptor alkylation for calculation of apparent agonist affinity. Br J Pharmacol. 1991 Aug;103(4):1951–1957. doi: 10.1111/j.1476-5381.1991.tb12358.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Emmerson J., Mackay D. A test of the null equation for functional antagonism. Br J Pharmacol. 1981 May;73(1):135–141. doi: 10.1111/j.1476-5381.1981.tb16782.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fleming W. W., Westfall D. P., De la Lande I. S., Jellett L. B. Log-normal distribution of equiefective doses of norepinephrine and acetylcholine in several tissues. J Pharmacol Exp Ther. 1972 May;181(2):339–345. [PubMed] [Google Scholar]
  13. Furchgott R. F. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol. 1984;24:175–197. doi: 10.1146/annurev.pa.24.040184.001135. [DOI] [PubMed] [Google Scholar]
  14. Ghai G., Mustafa S. J. Demonstration of a putative adenosine receptor in rabbit aorta. Blood Vessels. 1982;19(3):117–125. [PubMed] [Google Scholar]
  15. Godfrey K. Statistics in practice. Comparing the means of several groups. N Engl J Med. 1985 Dec 5;313(23):1450–1456. doi: 10.1056/NEJM198512053132305. [DOI] [PubMed] [Google Scholar]
  16. Headrick J. P., Berne R. M. Endothelium-dependent and -independent relaxations to adenosine in guinea pig aorta. Am J Physiol. 1990 Jul;259(1 Pt 2):H62–H67. doi: 10.1152/ajpheart.1990.259.1.H62. [DOI] [PubMed] [Google Scholar]
  17. Henry P. J., Lulich K. M., Paterson J. W. Experimental testing of Mackay's model for functional antagonism in the isolated costo-uterus of the rat. Br J Pharmacol. 1985 Sep;86(1):131–139. doi: 10.1111/j.1476-5381.1985.tb09443.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Herlihy J. T., Bockman E. L., Berne R. M., Rubio R. Adenosine relaxation of isolated vascular smooth muscle. Am J Physiol. 1976 May;230(5):1239–1243. doi: 10.1152/ajplegacy.1976.230.5.1239. [DOI] [PubMed] [Google Scholar]
  19. Keitz S. A., Osman R., Clarke W. P., Goldfarb J., Maayani S. Functional interactions in smooth muscle: kinetic characterization of the relaxation and desensitization responses to a beta adrenergic agonist in the rabbit aorta. J Pharmacol Exp Ther. 1990 Nov;255(2):650–656. [PubMed] [Google Scholar]
  20. King A. D., Milavec-Krizman M., Müller-Schweinitzer E. Characterization of the adenosine receptor in porcine coronary arteries. Br J Pharmacol. 1990 Jul;100(3):483–486. doi: 10.1111/j.1476-5381.1990.tb15833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Leff P., Martin G. R., Morse J. M. Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants. Br J Pharmacol. 1985 Jul;85(3):655–663. doi: 10.1111/j.1476-5381.1985.tb10561.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Leff P., Prentice D. J., Giles H., Martin G. R., Wood J. Estimation of agonist affinity and efficacy by direct, operational model-fitting. J Pharmacol Methods. 1990 May;23(3):225–237. doi: 10.1016/0160-5402(90)90066-t. [DOI] [PubMed] [Google Scholar]
  23. Lemoine H., Overlack C. Highly potent beta-2 sympathomimetics convert to less potent partial agonists as relaxants of guinea pig tracheae maximally contracted by carbachol. Comparison of relaxation with receptor binding and adenylate cyclase stimulation. J Pharmacol Exp Ther. 1992 Apr;261(1):258–270. [PubMed] [Google Scholar]
  24. Mackay D. An analysis of functional antagonism and synergism. Br J Pharmacol. 1981 May;73(1):127–134. doi: 10.1111/j.1476-5381.1981.tb16781.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Maxwell R. A., Eckhardt S. B., Wastila W. B. Concerning the distribution of endogenous norepinephrine in the adventitial and media-intimal layers of the rabbit aorta and the capacity of these layers to bind tritiated norepinephrine. J Pharmacol Exp Ther. 1968 May;161(1):34–39. [PubMed] [Google Scholar]
  26. McCormack D. G., Clarke B., Barnes P. J. Characterization of adenosine receptors in human pulmonary arteries. Am J Physiol. 1989 Jan;256(1 Pt 2):H41–H46. doi: 10.1152/ajpheart.1989.256.1.H41. [DOI] [PubMed] [Google Scholar]
  27. Molenaar P., Malta E. Analysis of agonist dissociation constants as assessed by functional antagonism in guinea pig left atria. J Pharmacol Methods. 1986 Apr;15(2):105–117. doi: 10.1016/0160-5402(86)90060-4. [DOI] [PubMed] [Google Scholar]
  28. Oriowo M. A., Ruffolo R. R., Jr Heterogeneity of postjunctional alpha 1-adrenoceptors in mammalian aortae: subclassification based on chlorethylclonidine, WB 4101 and nifedipine. J Vasc Res. 1992 Jan-Feb;29(1):33–40. doi: 10.1159/000158929. [DOI] [PubMed] [Google Scholar]
  29. Osman R., Keitz S. A., Goldfarb J., Maayani S. Kinetics of response and drug action. Neuropsychopharmacology. 1990 Oct-Dec;3(5-6):417–425. [PubMed] [Google Scholar]
  30. Sabouni M. H., Brown G. L., Kotake A. N., Douglas F. L., Mustafa S. J. Effects of CGS-15943A on the relaxations produced by adenosine analogs in human blood vessels. Eur J Pharmacol. 1990 Oct 23;187(3):525–530. doi: 10.1016/0014-2999(90)90381-f. [DOI] [PubMed] [Google Scholar]
  31. Sabouni M. H., Cushing D. J., Mustafa S. J. Adenosine receptor-mediated relaxation in coronary artery: evidence for a guanyl nucleotide-binding regulatory protein involvement. J Pharmacol Exp Ther. 1989 Dec;251(3):943–948. [PubMed] [Google Scholar]
  32. Stoggall S. M., Shaw J. S. The coexistence of adenosine A1 and A2 receptors in guinea-pig aorta. Eur J Pharmacol. 1990 Nov 13;190(3):329–335. doi: 10.1016/0014-2999(90)94197-6. [DOI] [PubMed] [Google Scholar]
  33. Wiener H. L., Murray J. M., Thalody G. P., Maayani S. Kinetics of relaxation responses to vasorelaxants in isolated rabbit aorta. Eur J Pharmacol. 1992 Sep 22;220(2-3):131–140. doi: 10.1016/0014-2999(92)90740-u. [DOI] [PubMed] [Google Scholar]
  34. van den Brink F. G. The model of functional interaction. I. Development and first check of a new model of functional synergism and antagonism. Eur J Pharmacol. 1973 Jun;22(3):270–278. doi: 10.1016/0014-2999(73)90026-5. [DOI] [PubMed] [Google Scholar]
  35. van den Brink F. G. The model of functional interaction. II. Experimental verification of a new model: the antagonism of beta-adrenoceptor stimulants and other agonists. Eur J Pharmacol. 1973 Jun;22(3):279–286. doi: 10.1016/0014-2999(73)90027-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES